Single-agent capecitabine as maintenance therapy after induction of XELOX (or FOLFOX) in first-line treatment of metastatic colorectal cancer: randomized clinical trial of efficacy and safety.
about
Single-agent capecitabine as maintenance therapy after induction of XELOX (or FOLFOX) in first-line treatment of metastatic colorectal cancer: randomized clinical trial of efficacy and safety.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Single-agent capecitabine as m ...... trial of efficacy and safety.
@en
Single-agent capecitabine as maintenance therapy after induction of XELOX
@nl
type
label
Single-agent capecitabine as m ...... trial of efficacy and safety.
@en
Single-agent capecitabine as maintenance therapy after induction of XELOX
@nl
prefLabel
Single-agent capecitabine as m ...... trial of efficacy and safety.
@en
Single-agent capecitabine as maintenance therapy after induction of XELOX
@nl
P2093
P2860
P356
P1433
P1476
Single-agent capecitabine as m ...... trial of efficacy and safety.
@en
P2093
P2860
P304
P356
10.1093/ANNONC/MDW101
P577
2016-03-02T00:00:00Z